Advanced Courses

ESMO-ESO Courses on Medical Oncology for Medical Students

These annual five-day residential courses enable students to get a full picture of this challenging and interesting professional field before making the choice of their specialisation.

Preceptorship Courses

Apply now to join one of our Preceptorship courses!

Workshops & Courses

ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.

Patient Guides

Guides for Patients are designed to assist patients, their relatives and caregivers to better understand the nature of different types of cancer and evaluate the best available treatment choices

Personalised Medicine Explained

Video interviews and articles designed to help patients, policy makers and other non-medical professionals better understand the principles of personalised cancer medicine

Getting the Most out of Your Oncologist

Now available in Romanian, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.

Designated Centres of Integrated Oncology and Palliative Care

The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.

EFPIA Disclosure Code

Policy News

Welcome to OncologyPRO, the home of ESMO’s educational and scientific resources, with Guidelines, a comprehensive list of E-Learning modules, Factsheets on biomarkers, slides and webcasts from our educational programme, and more... to support continuing medical education and daily practice!

New Treatments in Melanoma

The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did this E-Learning module provide an update on novel immunotherapies and targeted agents available for the treatment of patients with advanced melanoma, including associated biomarkers? (1-no, not at all; 5-yes, absolutely)

1

2

3

4

5

2. Did this E-Learning module provide an update on clinical results from recent randomised studies with immunotherapies and targeted agents in patients with advanced melanoma, including recommendation for a current therapeutic algorithm? (1-no, not at all; 5-yes, absolutely)

1

2

3

4

5

3. Did this E-Learning module provide insights on the profile of side-effects from novel immunotherapies and targeted agents available for the treatment of patients with advanced melanoma, including clinical guidance for their management? (1-no, not at all; 5-yes, absolutely)

1

2

3

4

5

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

1

2

3

4

5

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

1

2

3

4

5

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

1

2

3

4

5

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

1

2

3

4

5

8. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: